drugset / Trial / NCT00020371
BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have cancers that have not responded to previous therapy.
Timeline
- Start
- 2000-09
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ixabepilone | Small molecule | — | Intravenous |
| Background | filgrastim | Protein / enzyme biologic | — | — |